Atıf Formatları
Pharmacophore-Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. E. EVREN Et Al. , "Pharmacophore-Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity," ADVANCED THEORY AND SIMULATIONS , vol.8, no.1, 2025

EVREN, A. E. Et Al. 2025. Pharmacophore-Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity. ADVANCED THEORY AND SIMULATIONS , vol.8, no.1 .

EVREN, A. E., SAĞLIK ÖZKAN, B. N., AKALIN ÇİFTÇİ, G., & YURTTAŞ, L., (2025). Pharmacophore-Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity. ADVANCED THEORY AND SIMULATIONS , vol.8, no.1.

EVREN, ASAF Et Al. "Pharmacophore-Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity," ADVANCED THEORY AND SIMULATIONS , vol.8, no.1, 2025

EVREN, ASAF E. Et Al. "Pharmacophore-Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity." ADVANCED THEORY AND SIMULATIONS , vol.8, no.1, 2025

EVREN, A. E. Et Al. (2025) . "Pharmacophore-Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity." ADVANCED THEORY AND SIMULATIONS , vol.8, no.1.

@article{article, author={ASAF EVRİM EVREN Et Al. }, title={Pharmacophore-Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity}, journal={ADVANCED THEORY AND SIMULATIONS}, year=2025}